Submitted by Anonymous (not verified) on 25 March 2026 - 12:02
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 20, Status: Authorised